Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GSAC |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Gelstat Corp | 210.0K | -0.1x | --- |
Neutra Corp | 291.8K | -1.7x | --- |
Petlife Pharmaceuticals Inc | 19.7K | 0.0x | --- |
Oncology Pharma Inc | 40.0 | 0.0x | --- |
Nunzia Pharmaceutical Corp | 430.0 | 0.0x | --- |
Earth Life Sciences Inc | 100.0K | -0.2x | --- |
GelStat Corporation is engaged in research, development, marketing and branding of advanced technology operations. The Company's subsidiary, GSAC Engineering Corporation, is engaged in the development of technologies for clean energy and industrial security. The Company has acquired the intellectual property of Duos Technologies Group, Inc.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $210.0K |
---|---|
Revenue (TTM) | $1.7M |
Shares Outstanding | 525.0M |
Gelstat Corp does not pay a dividend. | |
Beta | 1.99 |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 0.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -72.67% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.